BackTom Alter, veteran actor, writer and director, dies of cancer at 67
Veteran theatre, film and television actor Tom Alter has passed away of skin cancer aged 67
Premium
Mumbai: Veteran theatre, film and television actor Tom Alter has passed away aged 67.
According to people in his family, Alter, who was battling skin cancer, passed away on Friday night at his residence in Mumbai.
“It is with sadness we announce the death of Tom Alter, actor, writer, director, Padma Shri, and our dear husband and father. Tom passed away on Friday night at home with his family and close family members in attendance. We ask for their privacy to be respected at this time," statement released on behalf of his family read.
Indian actor of American descent, Alter was the son of American missionary parents. He was born in 1950 in Mussoorie. He studied at Woodstock School in Mussoorie and later at Pune’s Film and Television Institute. The actor appeared in over 300 films which included Satyajit Ray’s acclaimed movie Shatranj Ke Khiladi and Junoon.
His first Hindi film to be released was Ramanand Sagar’s Charas in 1976. His acting credits also include Aashiqui, Parinda, Sardar Patel and Gandhi. In television, Alter’s work ranged from Bharat Ek Khoj to Shaktimaan. He also worked in Bengali, Assamese and Telugu cinema.
A cricket enthusiast, he also wrote for several sporting journals and was a published author. His last film was Sargoshiyan with Alok Nath and Farida Jalal. The film released in May this year. Alter’s presence in theatre has been noteworthy as well. His play, Ghalib In Delhi, was performed across the country. He played the lead role of legendary poet Mirza Ghalib.
Alter was also a sports journalist and was the first person to interview Sachin Tendulkar for TV when the cricketer was yet to debut for India. The actor was awarded Padma Shri in 2008 for his services to the field of arts and cinema. Alter is survived by his wife Carol, son Jamie, and daughter Afshaan.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!
